RNF213 Antikörper (N-Term)
Kurzübersicht für RNF213 Antikörper (N-Term) (ABIN928203)
Target
Alle RNF213 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- KIAA1618 antibody was raised in rabbit using the N terminal of KIAA1618 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
KIAA1618 Blocking Peptide, catalog no. 33R-4644, is also available for use as a blocking control in assays to test for specificity of this KIAA1618 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- RNF213 (Ring Finger Protein 213 (RNF213))
-
Andere Bezeichnung
- KIAA1618
-
Hintergrund
- Translocation t(2,17)(p23,q25) with ALK, a chromosomal aberration involving ALO17 is associated with anaplastic large-cell lymphoma. Synonyms: Polyclonal KIAA1618 antibody, Anti-KIAA1618 antibody, KIAA1618 antibody.
Target
-